Ethical Compliance
KOPRAN
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
small
Revenue
0.4%
Debt
13.4%
Liquidity
1.9%
Revenue
Debt
Liquidity
0.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Products | ₹474.28 |
| Scrap Sales | ₹1.67 |
| Export Incentive | ₹1.51 |
| Others | ₹0.06 |
| Liabilities Written Back (net) | ₹0.73 |
| Net Gain on Foreign Currency Transaction and Translation | ₹7.48 |
Questionable
INR Crores
| Recovery of Bad Debts Earlier Written Off | ₹0.62 |
| Dividend Income Long - Term Investments | ₹0.00 |
| Miscellaneous Income | ₹0.45 |
Non Compliant
INR Crores
| Interest Income On Fixed Deposit | ₹0.79 |
| Interest Income On Others | ₹0.54 |
INR Crores
| Revenue from Questionable Sources: | ₹1.07 |
| Revenue from Non Compliant Sources: | ₹1.32 |
| Total: | ₹2.40 |
| Total Revenue: | ₹614.59 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹2.40
₹614.59
= 0.4%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
